- Previous Close
67,000.00 - Open
66,000.00 - Bid 68,000.00 x --
- Ask 68,100.00 x --
- Day's Range
64,700.00 - 69,200.00 - 52 Week Range
31,000.00 - 99,400.00 - Volume
1,705,082 - Avg. Volume
1,104,968 - Market Cap (intraday)
1.96T - Beta (5Y Monthly) 1.82
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
58,000.00
Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.
www.lunit.io--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 328130.KQ
View More
Performance Overview: 328130.KQ
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 328130.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 328130.KQ
View MoreValuation Measures
Market Cap
1.93T
Enterprise Value
1.92T
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
48.86
Price/Book (mrq)
8.29
Enterprise Value/Revenue
48.54
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-84.72%
Return on Assets (ttm)
-14.44%
Return on Equity (ttm)
-14.62%
Revenue (ttm)
26.03B
Net Income Avi to Common (ttm)
-22.06B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
106.05B
Total Debt/Equity (mrq)
27.55%
Levered Free Cash Flow (ttm)
80.17B
Research Analysis: 328130.KQ
View MoreCompany Insights: 328130.KQ
328130.KQ does not have Company Insights